GlaxoSmithKline PLC Director/PDMR Shareholding (7172X)
February 23 2017 - 10:07AM
UK Regulatory
TIDMGSK
RNS Number : 7172X
GlaxoSmithKline PLC
23 February 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ========================================================================
a) Name Dr M M Slaoui
=== ======================== ==============================================
b) Position/status Chairman, Global Vaccines
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
=== ======================== ==============================================
b) Nature of the An increase of 53 ADSs following the notional
transaction allocation of ADSs on 22 February 2017,
at a price of $41.03 per ADS, as a result
of the revaluation of the cash element
of the notional investment held within
the GSK 401(K) plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$41.03 53
--------- ----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2017-02-22
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ========================================================================
a) Name Dr K Slaoui
=== ======================== ==============================================
b) Position/status PCA of Dr M M Slaoui (Chairman, Global
Vaccines)
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
=== ======================== ==============================================
b) Nature of the An increase of 13 ADSs following the notional
transaction allocation of ADSs on 22 February 2017,
at a price of $41.03 per ADS, as a result
of the revaluation of the cash element
of the notional investment held within
the GSK 401(K) plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$41.03 13
--------- ----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2017-02-22
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEXLFLDLFBBBZ
(END) Dow Jones Newswires
February 23, 2017 10:07 ET (15:07 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
